$CELC news
The latest CELC stock news: headlines, filings, AI summaries and sentiment for $CELC, updated around the clock.
- Celcuity Reports Q3 2026 Financial Results and Revtopik Commercial Launch Progress
- Celcuity Reports Third Quarter 2026 Non-GAAP EPS Beat
- Celcuity Inc. - 10-Q Filing
- Celcuity Inc. - 8-K Filing
- Celcuity Reports Improved Progression-Free Survival with Revtorpyk in Phase 3 Breast Cancer Trial
- Celcuity Inc. - 8-K Filing
- Celcuity Stock Rises on Launch of First Commercial Product
- Celcuity Inc. - 8-K Filing
- Celcuity's FDA Approval of Revtopik Faces Challenges with High Launch Costs
- Celestica Reports Q2 Revenue Surge of 62% and Raises FY2026 Free Cash Flow Outlook to $600M
- Investor Alert: Pomerantz Law Firm Investigates Celcuity Inc.
- Celcuity Inc. - 8-K Filing
- Celcuity Shares Drop Despite FDA Approval for Breast Cancer Drug
- Celcuity Inc. - 8-K Filing
- FDA Approves Celcuity's Gedatolisib in Combination Therapy for Breast Cancer
- Celcuity Inc. - 8-K Filing
- Celcuity raises $500 million in upsized convertible senior notes offering
- Celcuity Inc. - 8-K Filing
- Soleus Capital Adds $63M to Vericel Stake Amid Revenue Growth
- Celcuity Inc. - 8-K Filing
- Celcuity Inc. - 8-K Filing